NOVO — August 2023
-
Her er et overblik over finanshusenes ændringer af kursmål og anbefalinger efter kvartalsregnskabet torsdag og hjerte-kar-studiet med Wegovy tirsdag:
-
ABG Sundal Collier Køb Køb 1400 1250
Jyske Bank Hold Hold 1325 1175
Nordea Køb Køb 1345 1273
Barclays Overvægt Overvægt 1450 1350
Morningstar Sælg Sælg 950 900
DNB Hold Køb 1330 1380
-
Morningstar Sælg Sælg 950 900
Danske Bank Køb Køb 1525 1275
-
MarketWire
-
Novo Nordisks kursmål hæves på stribe efter uge med regnskab og Select-studie https://www.proinvestor.com/investornyt/1032827/novo-nordisks-kursmal-haeves-pa-stribe-efter-uge-med-regnskab-og-select-studie
-
Novo-insidere sælger aktier for 29 mio. kr. https://www.proinvestor.com/investornyt/1032951/novo-insidere-saelger-aktier-for-29-mio-kr
-
Aktier: Faresignaler har overtaget i sensommeren https://www.proinvestor.com/boards/114657
-
Up 45% This Year What's Driving The Growth For Eli Lilly Stock? https://www.proinvestor.com/investornyt/1033881/up-45-this-year-whats-driving-the-growth-for-eli-lilly-stock
-
Eli Lilly har også taget endnu mere forskud på fedme mulighederne end novo
-
Eli Lilly gennemfører milliardopkøb af fedmefokuseret biotekselskab https://www.proinvestor.com/investornyt/1034067/eli-lilly-gennemforer-milliardopkob-af-fedmefokuseret-biotekselskab
-
Så kom første land der nu vil give tilskud til Wegovy. UK. Dem med en bmi over 35 plus mindst en fedme relateret sygedom
-
Tror det er derfor aktien pludselig
steg -
‘Game changer’ weight loss jab to become available on NHS
-
-
he committee also discussed the concern about the reliability of using risk equations to predict cardiovascular events. It noted that these were predictions alone and not based on clinical evidence (see section 3.16). However, although this remained an uncertainty, semaglutide was still cost effective if these benefits were not included in the model
-
Hvis du vil læser NICE rapporten ang støtte til Semaglutide. https://www.nice.org.uk/guidance/ta875
-
Tak for link Lahn1. Jeg bliver nu stadig ikke for alvor klogere på hvordan de kommer helt ned til 48.000. Men jeg tror mere der er tale om det wegovy pilot forsøg de selv vil sponsere. Som så skal danne grundlag for et mulig meget bredere tilskud
-
Ministers launch £40m pilot scheme to trial wider access to slimming jab
Less regulation of weight-loss drug would make Wegovy accessible to more people
the Guardian (www.theguardian.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind